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ABSTRACT 
OBJECTIVE: To acquire data on pediatric nosocomial 
infections (NIs), which are associated with substantial morbidity 
and mortality and for which data are scarce. 
DESIGN: Prevalence survey and evaluation of a new 
comorbidity index. 
SETTING: Seven Swiss pediatric hospitals. 
PATIENTS: Those hospitalized for at least 24 hours in a 
medical, surgical, intensive care, or intermediate care ward. 
RESULTS: Thirty-five NIs were observed among 520 
patients (6.7%; range per hospital, 1.4% to 11.8%). Bacteremia was 
most frequent (2.5 per 100 patients), followed by urinary tract 
infection (1.3 per 100 patients) and surgical-site infection (1.1 per 
100 patients; 3.2 per 100 patients undergoing surgery). The medi-
an duration until the onset of infection was 19 days. Independent 
risk factors for NI were age between 1 and 12 months, a comor-
bidity score of 2 or greater, and a urinary catheter. Among surgi-
cal patients, an American Society of Anesthesiologists (ASA) 
score of 2 or greater was associated with any type of NI (P = .03). 
Enterobacteriaceae were the most frequent cause of NI, followed 
by coagulase-negative staphylococci; viruses were rarely the 
cause. 
CONCLUSIONS: This national prevalence survey yield-
ed valuable information about the rate and risk factors of pedi-
atric NI. A new comorbidity score showed promising perfor-
mance. ASA score may be a predictor of NI. The season in which 
a prevalence survey is conducted must be considered, as this 
determines whether seasonal viral infections are observed. 
Periodic prevalence surveys are a simple and cost-effective 
method for assessing NI and comparing rates among pediatric 
hospitals (Infect Control Hosp Epidemiol 2004;25:765-771). 
Nosocomial infections are associated with a high 
burden of excess morbidity and mortality in both adults 
and children.12 In Switzerland, as in other countries, an 
average of 5% to 10% of all hospitalized adults acquire a 
nosocomial infection.1,34 
Children's hospitals serve a unique patient popula-
tion, one that differs in many respects, including infection 
control, from the adult patient population.5 However, com-
pared with adults, few data are available concerning noso-
comial infections among children. Their frequency seems 
to be, on average, lower among children and differs sub-
stantially depending on age group and hospital unit sur-
veyed.6"14 For example, the highest nosocomial infection 
rates have been described for neonates, infants, and 
patients in intensive care or surgical units. 
Surveillance is important for controlling nosocomi-
al infections.15 However, depending on the methodology 
employed, assessing nosocomial infections can be costly. 
Prevalence surveys are the least costly type of surveil-
lance for nosocomial infections and provide valuable infor-
mation, especially when repeated at regular intervals.346 
Relatively small numbers of patients in high-risk groups 
(eg, patients in pediatric and neonatal intensive care 
units) may hamper the success of prevalence studies. 
However, prevalence surveys can provide valuable infor-
mation on the overall rate of pediatric nosocomial infec-
tions and, in multicenter studies, can also provide infor-
mation on high-risk patients.61214 
Comorbidity scores are used for case-mix adjust-
ment in surveys of nosocomial infections among the gen-
eral adult patient population. For example, the Charlson 
score, the Karnofsky index, and the McCabe and Jackson 
classification have been shown to correlate with the risk 
of nosocomial infection in prevalence surveys.34 However, 
no such score exists for the general pediatric patient pop-
ulation. 
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TABLE 1 
SCORES OF THE COMORBIDITY INDEX FOR THE 
Illness or Condition 
Asthma 
Cystic fibrosis 
Other chronic pulmonary disease 
Neoplasm-solid tumor 
Leukemia 
Lymphoma 
Congenital immunodeficiency 
HIV infection 
Metabolic disease 
Vesicoureteral reflux 
Congenital heart defect—cyanotic 
Congenital heart defect—non-cyanotic 
Liver cirrhosis 
Malformation syndromes 
Total 
HIV = human immunodeficiency virus. 
PATIENTS 
Score 
1 
2 
1 
2 
2 
2 
2 
2 
1 
2 
2 
1 
2 
1 
Sum of fulfilled 
criteria for a 
given study patient 
This article reports the results of a prevalence sur-
vey of nosocomial infections in Swiss children's hospitals 
conducted in May 2000. A special feature of this study was 
the evaluation of a new comorbidity index for children. 
METHODS 
A prevalence survey was performed in seven pedi-
atric hospitals in Switzerland between May 17 and May 
19, 2000. Data were collected from all medical and surgi-
cal wards and intensive and intermediate care units. 
Wards with a patient stay of less than 24 hours were 
excluded.3,4 Intensive care units were defined as units 
with intensive monitoring and artificial ventilation. In 
intermediate care units, intensive monitoring was per-
formed, but not artificial ventilation. The total number of 
hospital beds surveyed was 969 (average number per hos-
pital, 138 beds; range, 72 to 247 beds). This covered 
approximately 70% of all Swiss pediatric hospital 
beds. 
The study population consisted of all patients hospi-
talized for at least 24 hours at each of the seven hospitals. 
A standardized questionnaire was completed for every 
patient. Sociodemographic and clinical data were ascer-
tained by reviewing nursing and medical charts and, if 
necessary, by receiving additional information from the 
hospital staff. No additional clinical examinations or analy-
ses were performed. 
All active (ie, symptomatic or under treatment) 
nosocomial infections present on the study day or during 
1 of the 6 previous days were documented. Surgical-site 
infections were included when evident if they had onset 
within 30 days following surgery, or within 1 year in the 
case of infection associated with an implant. A nosocomi-
al infection was defined as an infection occurring 48 hours 
or more after hospitalization or birth and not demonstrat-
ing any sign of incubation or illness at admission. In addi-
tion, a nosocomial infection had to meet all requirements 
of the standardized and minimally adapted definitions of 
the Centers for Disease Control and Prevention for pedi-
atric patients.16 The important adaptation was that the age 
restriction in the specific definitions for pneumonia and 
lower respiratory tract infection was raised from 1 to 7 
years. 
The primary diagnosis was classified according to 
the 20 diagnostic groups defined by the International 
Classification of Diseases, 9th revision, Clinical 
Modification.17 
A new score based on an adapted version of the 
Charlson score was created for the assessment of comor-
bidity (Table l).18 For surgical patients, the American 
Society of Anesthesiologists (ASA) score was obtained. 
Information was obtained concerning the presence 
of indwelling devices and the consumption of antibiotics 
during the 7 days before a patient met the criteria for 
nosocomial infection or during the 7 days before the study 
day. Data were also collected concerning surgery occur-
ring during the 30-day period preceding the study day (1 
year in the case of an implant). If a patient underwent sev-
eral interventions, data were collected for the surgery 
associated with the highest expected risk for nosocomial 
infection. 
The questionnaire was tested at each hospital prior 
to the study. During the study, every questionnaire was 
reviewed and, if necessary, completed by the hospital 
coordinator. 
Risk factors for nosocomial infection identified by 
univariate analysis were entered into a logistic regression 
model (StatView, version 5.0; SAS Institute, Inc., Cary, 
NC), with the exception of variables that were collected 
only for patients undergoing surgery. The final model 
comprised all variables that remained significantly associ-
ated with nosocomial infection on adjustment. 
Proportions were compared using the chi-square or 
Fisher's exact test as appropriate. Differences between 
means were assessed using Student's t test. A two-tailed P 
value of .05 or less was used to define statistical signifi-
cance for all analyses. 
RESULTS 
The study population consisted of 520 patients 
(range per hospital, 45 to 103 patients). Medical wards 
contributed most of the patients (48.0%), followed by sur-
gical wards (31.7%), intensive care units (10.2%), and 
intermediate care units (10.2%) (Table 2). Almost half 
(48.0%) of the study patients were between 5 and 16 years 
old and neonates comprised 22.3% of the patients. 
Approximately one-third of the patients required intensive 
care (28.8%) or had surgery (35.5%) prior to the study day. 
A high proportion of patients (63.9%) had an intravascular 
catheter; 8.3% had a bladder catheter and 6.7% were intu-
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bated at some time during their hospitalization before the 
study day. 
A total of 35 nosocomial infections were found 
among 34 children for an overall attack rate of 6.7 noso-
comial infections per 100 patients (95% confidence inter-
val [CI95], 4.6 to 8.8). The infection rate ranged between 
1.4% and 11.8% in the different hospitals. The most fre-
quent type of nosocomial infection was bloodstream infec-
tion (37.1%; 2.5 per 100 patients), followed by urinary tract 
infection (20%; 1.3 per 100 patients) and surgical-site infec-
tion (17.1%; 1.1 per 100 patients and 3.2 per 100 patients 
who underwent surgery) (Table 3). Upper and lower res-
piratory tract infections (0.3 and 1.0 per 100 patients, 
respectively) and gastrointestinal infections (0.4 per 100 
patients) were rare (Table 3). The infection rate was high-
est among infants 1 to 12 months old (14.5 per 100 
patients), followed by neonates (6.9 per 100 patients), 
young children (5.6 per 100 patients), and older children 
(4.4 per 100 patients) (Table 2). Patients in intermediate 
care units had a higher nosocomial infection rate (13.2 per 
100 patients) than did patients in intensive care units (7.5 
per 100 patients) or patients in surgical (3.6 per 100 
patients) or medical wards (7.2 per 100 patients). High 
rates were also observed for patients with a comorbidity 
score of 2 or greater (16.4 per 100 patients), and for 
patients with a urinary catheter (14.0 per 100 patients). 
The median duration until the onset of a nosocomial infec-
tion was 19 days (range, 2 to 145 days). 
Endogenous risk factors for nosocomial infection 
included age between 1 and 12 months (odds ratio [OR], 
3.67; CI95,1.55 to 8.69), a comorbidity score of 2 or greater 
(OR, 2.85; CI95, 1.20 to 6.80), and hospitalization due to a 
neoplasm (OR, 4.76; CIg5, 1.63 to 14.28) or congenital ill-
ness (OR, 4.16; CI%, 1.47 to 11.10) (Table 2). Exogenous 
risk factors included a stay in an intermediate care unit 
(OR, 4.16; CI95, 1.29 to 12.5), surgery during the past 30 
days (or 1 year in the case of placement of a foreign body; 
OR, 2.14; CI95, 1.06 to 4.31), and the presence of an 
intravascular catheter (OR, 2.35; CI95, 1.02 to 5.45) or a 
urinary catheter (OR, 2.60; CI95,1.01 to 6.68) (Table 2). In 
the logistic regression model, independent risk factors for 
nosocomial infection were age between 1 and 12 months, 
a comorbidity score of 2 or greater, and the presence of a 
urinary catheter (Table 4). 
Among surgical patients (n = 185), an ASA score of 
2 or greater was significantly associated with any type of 
nosocomial infection (chi-square test for trend, P = .03) 
(Table 2). Five of 13 bloodstream infections were associ-
ated with an intravascular catheter, 4 of 7 urinary tract 
infections with a urinary catheter, and 1 of 2 pneumonias 
with mechanical ventilation. 
A pathogen was isolated for 24 of the 35 nosocomi-
al infections. A single microorganism was found in 83.3% 
of these infections, and 16.7% were polymicrobial infec-
tions. Enterobacteriaceae (excluding Escherichia colt) 
were the most frequent pathogens (37.5%) isolated, fol-
lowed by coagulase-negative staphylococci (29.2%) (Table 
5). 
DISCUSSION 
In this pediatric multicenter survey, the overall 
prevalence of nosocomial infections was 6.7%. The 
observed nosocomial infection rate varied among the 
seven participating hospitals. These differences did not 
reach statistical significance, although the relatively small 
number of patients surveyed in some of the hospitals did 
not permit calculation of standardized or adjusted nosoco-
mial infection rates.4-19 The nosocomial infection rate 
observed in this study lies within the range of infection 
rates (2.3% to 12.6%) reported from earlier pediatric stud-
ies, but comparisons are hampered by the use of different 
methods in different studies.671012 Published studies 
either used several types of longitudinal surveys,7'9,10'2021 
concentrated on high-risk populations,891114 or both. 
Consistent with earlier findings, the frequency of 
nosocomial infections was highest among infants.7 In the 
current study, intermediate care units were found to have 
the highest infection rate (13.2 per 100 patients), which 
was even higher than that observed in intensive care 
units. A comparison with other published studies is not 
possible, as no earlier study differentiated between these 
two types of units. 
Our data confirm the relatively high proportion of 
bloodstream infections among pediatric patients, which 
contrasts with the predominance of urinary tract infec-
tions and surgical-site infections among adults.6'7101114 
Our rate of 2.5 bloodstream infections per 100 patients is 
higher than that observed by others, but these studies dif-
fered in methods used.710 
The rate of urinary tract infections (1.3 per 100 
patients) was well within the previously reported range 
(0.36 to 5.2 per 100 patients) and was less than that report-
ed among adults.3'67'1012'14 
Surgical-site infections were the third most fre-
quent nosocomial infection in this study. The observed 
rate (3.2 per 100 patients undergoing surgery) is relative-
ly high compared with other studies. The rate is also high 
considering the fact that, in a prevalence survey, a con-
siderable proportion of postdischarge infections (approxi-
mately 35%) are usually missed.22 In this study, the pro-
portion of patients with an ASA score of 2 or greater was 
significantly higher than that in another study.21 In a 
prevalence study, patients with a long hospital stay have 
an increased chance of being surveyed and they also have 
an increased risk of nosocomial infection. This may be 
reflected in the comparatively high frequency of surgical-
site infections observed in this study. 
Respiratory tract infection is a common clinical 
manifestation of nosocomial infection in children.6'7101214 
The low rate of lower respiratory tract infections 
observed in the current study (1.0 per 100 patients) is 
comparable to previously reported rates.71114 As in adults, 
nosocomial lower respiratory tract infections in children 
are strongly associated with artificial ventilation.611 Lower 
respiratory tract infections are more common in pediatric 
intensive care units than in neonatal units.1011 However, 
an additional, unique feature of pediatric nosocomial res-
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TABLE 2 
CHARACTERISTICS OF THE 520 PATIENTS FROM THE SEVEN CHILDREN'S HOSPITALS AND RISK FACTORS FOR NOSOCOMIAL INFECTIONS ON 
UNIVARIATE ANALYSIS 
No. of patients1' 
Ward or unit (%) 
Surgical 
Intensive care 
Intermediate care 
Medical 
Age (96) 
Neonate 
1 to 12 mo 
13 to 48 mo 
5 to 16 y 
Hospital (%) 
A 
B 
C 
D 
E 
F 
G 
Male (%) 
Median duration of stay, d' 
Median duration of stay before 
study day, d 
Emergency referral (%) 
Surgery (%) 
Intensive care unit before 
study day (%) 
Hospitalized for (96) § 
Infection 
Neoplasm 
Congenital illness 
Perinatal illness 
Trauma 
Other 
Comorbidity score (%)" 
0 
1 
2 
>2 
Intravascular catheter (%) 
Central catheter 
Urinary catheter (%) 
Antibiotic prophylaxis (%) 
Surgical 
Other 
American Society of Anesthesiologists 
score (96)1 
1 
2 
3 
4 
Infected 
35 
6 (17.1) 
4 (11.4) 
7 (20.0) 
18 (51.4) 
8 (22.9) 
12 (34.3) 
4 (11.4) 
11 (31.4) 
3 (8.6) 
1 (2.9) 
2 (5.7) 
10 (28.6) 
7 (20.0) 
5 (14.3) 
7 (20.0) 
24 (68.6) 
30.0 
28.0 
23 (65.7) 
18 (51.4) 
14 (40.0) 
6 (17.1) 
7 (20.0) 
8 (22.9) 
3 (8.6) 
2 (5.7) 
9 (25.7) 
21 (60.0) 
5 (14.3) 
8 (22.9) 
1 (2.9) 
28 (80.0) 
8 (22.9) 
6 (17.1) 
13 (37.1) 
8 (61.5) 
3 (23.0) 
1 (5.8) 
8 (47.1) 
8 (47.1) 
0(0) 
Not 
Infected 
486 
159 (32.7) 
49 (10.1) 
46 (9.4) 
232 (47.7) 
108 (22.3) 
71 (14.6) 
67 (13.8) 
239 (49.2) 
42 (8.6) 
71 (14.6) 
82 (16.9) 
76 (15.6) 
58 (11.9) 
61 (12.6) 
96 (19.8) 
247 (50.9) 
12.0 
5.0 
315 (64.8) 
167 (34.4) 
136 (28.0) 
115 (23.7) 
30 (6.2) 
40 (8.2) 
71 (14.6) 
49 (10.1) 
181 (37.3) 
353 (72.6) 
78 (16.0) 
49 (10.1) 
6 (1.2) 
305 (62.8) 
54 (11.1) 
37 (7.6) 
115 (23.7) 
52 (45.2) 
65 (56.5) 
62 (38.0) 
50 (30.7) 
42 (25.8) 
9 (5.5) 
OR* 
Reference 
2.17 
4.16 
2.08 
1.29 
3.67 
1.61 
Reference 
Reference 
0.19 
0.34 
1.85 
1.69 
1.14 
1.02 
1.99 
1.04 
2.14 
1.71 
1.05 
4.76 
4.16 
0.85 
0.82 
Reference 
Reference 
1.07 
2.74 
2.36 
2.35 
2.60 
Reference 
10.00 
10.00 
c» 
0.58-8.33 
1.29-12.5 
0.80-5.55 
0.40-4.20 
1.55-8.69 
0.62-4.11 
0.01-1.96 
0.05-2.12 
0.48-7.14 
0.41-7.14 
0.26-5.26 
0.25-4.16 
0.95-4.16 
0.50-2.14 
1.06-4.31 
0.84-3.41 
0.36-3.03 
1.63-14.28 
1.47-11.1 
0.22-3.22 
0.17-4.00 
0.39-2.94 
1.19-6.32 
1.01-5.51 
1.02-5.45 
1.01-6.68 
1.20-100 
1.17-100 
P 
.1 
.003 
.01 
.09 
.06 
<.001 
<.001 
.91 
.02 
.13 
.001 
.04 
.88 
.01 
.04 
.03 
.04 
.03 
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TABLE 2 (cont'd) 
CHARACTERISTICS OF THE 520 PATIENTS FROM THE SEVEN CHILDREN'S HOSPITALS AND RISK FACTORS FOR NOSOCOMIAL INFECTIONS ON 
UNIVARIATE ANALYSIS 
Infected 
Not 
Infected OR* CL 
Wound class (56)11 
I 
II 
III 
rv 
12 (75.0) 
2 (12.5) 
1 (6.2) 
1 (6.2) 
74 (46.0) 
59 (36.6) 
12 (7.5) 
16 (9.9) 
Reference 
4.78 
1.94 
2.59 
1.03-22.21 
0.23-16.36 
0.31-21.41 
.15 
OR = odds ratio; CI95 = 95% confidence interval. 
* Adjusted ORs are presented for age, comorbidity score, and urinary catheter, which were independent risk factors for nosocomial infection in a logistic regression model. Crude ORs are presented 
for all other variables. 
fOne patient had two nosocomial infections and is counted twice in this table. 
^Obtained from 6 of the hospitals. 
•^ According to the International Classification of Diseases, 9th revision, Clinical Modification. 
^Underlying illness score (see METHODS and Table 1). For statistical analyses, patients with a score of 2 or greater were pooled. 
^Restricted to patients with surgery, but counting all nosocomial infections. For statistical analyses, patients with an American Society of Anesthesiologists score of 3 or 4 were pooled. 
piratory tract infection is the contribution of viral agents 
such as respiratory syncytial virus.7 The strong seasonal-
ity of viral respiratory tract infections is likely to be 
reflected in the rate of nosocomial upper respiratory tract 
infections and lower respiratory tract infections. This like-
ly explains the higher proportion of nosocomial infections 
caused by respiratory syncytial virus in other studies.710,20 
Access to and use of accurate rapid diagnostic methods 
for respiratory syncytial virus may also influence the 
observed frequency of viral infections; such tests were 
routinely used in all of the hospitals participating in this 
study. Timing should therefore be considered when plan-
ning a survey of nosocomial infection or comparing pedi-
atric nosocomial infection rates. Longitudinal studies are 
more likely to reflect the seasonality of viral nosocomial 
infections than are prevalence surveys. Analogous con-
clusions can be reached regarding viral gastrointestinal 
infections. Our survey was conducted in May, well after 
the respiratory syncytial virus, influenza, and rotavirus 
seasons, which may explain the relatively low rates of 
nosocomial respiratory tract infections and gastrointesti-
nal tract infections observed. 
The major pathogens causing nosocomial infections 
in this study were Enterobacteriaceae and coagulase-nega-
tive staphylococci. These findings correspond with find-
ings from earlier surveys of nosocomial infection in pedi-
atric hospitals and intensive care units.11,1214 In contrast to 
nosocomial infections among adult patients, Staphylococcus 
aureus may play a smaller role in nosocomial infections 
among children.3,4 Viral pathogens were relatively rare in 
this study.7,10,20 As discussed above, this was most likely 
due to the timing of our survey. 
It is well established that the use of indwelling 
devices increases the risk of nosocomial infection.3,7,1011 
Although limited information on device use was collected 
in this study, a significant association was observed 
between nosocomial infection and intravascular or uri-
TABLE 3 
DISTRIBUTION OF THE 35 NOSOCOMIAL INFECTIONS BY 
LOCATION 
Bloodstream infection 
Clinical sepsis 
Laboratory confirmed* 
Urinary tract infection 
Asymptomatic 
Symptomatic 
Surgical-site infection 
Superficial-incisional 
Deep-incisional 
Organ-space 
Lower respiratory tract infection 
Bronchitis 
Pneumonia 
Gastrointestinal infection 
Gastroenteritis 
Intraabdominal 
Otitis media 
Sinusitis 
No. 
13 
4 
9 
7 
1 
6 
6 
4 
1 
1 
5 
3 
2 
2 
1 
1 
1 
1 
% 
37.1 
11.4 
25.7 
20.0 
2.9 
17.1 
17.1 
11.4 
2.9 
2.9 
14.3 
8.6 
5.7 
5.7 
2.9 
2.9 
2.9 
2.9 
ANATOMIC 
Per 100 
Patients 
2.5 
0.8 
1.7 
1.3 
0.2 
1.2 
3.2 
2.1 
0.5 
0.5 
1.0 
0.6 
0.4 
0.4 
0.2 
0.2 
0.2 
0.2 
*Four of the nine were caused by Enterobacteriaceae, three by coagulase-negative staphylococ-
ci, one by Streptococcus sanguis, and one by Enterococcus species. 
^Calculation of rate per 185 patients who underwent surgery 30 days or 12 months (if a foreign 
body was implanted) before the study day. 
nary catheters. Device use was less frequent than among 
adult patients.3 A comparison with other published pedi-
atric studies is not possible due to the lack of data. 
Several comorbidity scores are used for case-mix 
adjustment in general adult patient populations. For exam-
ple, the Charlson score, the Karnofsky index, and the 
McCabe and Jackson classification have been shown to 
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TABLE 4 
MULTIVARIATE ANALYSIS OF RISK FACTORS FOR NOSOCOMIAL INFECTIONS AMONG THE PATIENTS 
Infected Not Infected OR CL, 
No. of patients* 
Age (%) 
Neonate 
1 to 12 mo 
13 to 48 mo 
5 to 16 y 
Comorbidity score (%)f 
0 
1 
2 
>2 
Urinary catheter (%) 
35 486 
8 (22.9) 
12 (34.3) 
4 (11.4) 
11 (31.4) 
21 (60.0) 
5 (14.3) 
8 (22.9) 
1 (2.9) 
6 (17.1) 
108 (22.2) 
71 (14.6) 
67 (13.8) 
239 (49.2) 
353 (72.6) 
78 (16.0) 
49 (10.1) 
6 (1.2) 
37 (7.6) 
1.59 
3.75 
1.24 
Reference 
Reference 
1.08 
2.85 
2.55 
0.38-4.09 
1.56-9.00 
0.40-4.34 
0.39-3.03 
1.20-6.80 
0.97-6.75 
.003 
.01 
.04 
.87 
.01 
.05 
OR =• odds ratio; CI,)r) = 95% confidence interval. 
*One patient had two nosocomial infections and is counted twice in this table. 
tUnderlying illness score (see METHODS and Table 1). For statistical analyses, patients with a score of 2 or greater were pooled. 
TABLE 5 
MICROORGANISMS ISOLATED FROM THE 24 NOSOCOMIAL 
INFECTIONS 
Enterobacteriaceae (Escherichia coli excluded) 
Coagulase-negative staphylococci 
Escherichia coli 
Enterococcus species 
Staphylococcus aureus 
Streptococcus species 
Pseudomonas aeruginosa 
Other (Acinetobacter species and Bacillus species) 
Polymicrobial (> 1 pathogen isolated) 
Respiratory syncytial virus 
No. 
9 
7 
3 
3 
1 
1 
1 
2 
4 
1 
% 
37.5 
29.2 
12.5 
12.5 
4.2 
4.2 
4.2 
8.3 
16.7 
4.2 
correlate with the risk of nosocomial infection in preva-
lence surveys.34 No such score has been established for 
the general pediatric patient population. A new comorbid-
ity index, corresponding to an adapted version of the 
Charlson score, was used in this study.18 The result was 
promising, with a score of greater than 1 being signifi-
cantly associated with an increased risk of nosocomial 
infection. Additional studies are needed to validate and 
further adapt this comorbidity score. 
ASA score is an established predictor of surgical-
site infection among adults.19,23 However, there is little 
information about its performance among pediatric 
patients. In a prospective, multicenter, pediatric survey, 
no association was found between ASA score and the risk 
of wound infection.21 This was probably due to the high 
proportion of pediatric patients with a low ASA score. In 
the current study, the small number of surgical-site infec-
tions did not allow an evaluation of ASA score for this type 
of nosocomial infection. However, ASA score was signifi-
cantly associated with an increased risk of any type of 
nosocomial infection among surgical patients. Therefore, 
ASA score may be useful as a more general comorbidity 
score. It remains to be determined whether this applies 
only to prevalence surveys that select for a patient popu-
lation with a higher comorbidity rate. 
This prevalence survey of nosocomial infections in 
Swiss children's hospitals supplied valuable information 
concerning the frequency of such infections and exoge-
nous and endogenous risk factors. A new comorbidity 
score showed promising performance, and its validation 
in future studies seems warranted. ASA score may also 
be a predictor of the overall rate of nosocomial infection, 
when used in prevalence surveys of hospitalized chil-
dren. Prevalence surveys are a simple and cost-effective 
method of assessing nosocomial infections and have 
great potential value for the prevention of these infec-
tions. This study suggests that prevalence surveys 
should be conducted on a regular basis in pediatric hos-
pitals. 
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